On Tuesday, May 27, an analyst from BTIG downgraded Globus Medical Inc. (NYSE:GMED) from Buy to Neutral, citing concerns ...

BTIG analysts have downgraded Globus Medical from "Buy" to "Neutral" amid fears surrounding the company's Spine business.

Across the recent three months, 6 analysts have shared their insights on Globus Medical GMED, expressing a variety of opinions spanning from bullish to bearish. Summarizing their recent ...

Globus Medical reported its financial results for Q1 2025, revealing a miss on both earnings and revenue forecasts. The company posted an earnings per share (EPS) of $0.68, falling short of the ...

AUDUBON, Pa. (AP) — AUDUBON, Pa. (AP) — Globus Medical Inc. (GMED) on Thursday reported first-quarter earnings of $75.5 million. On a per-share basis, the Audubon, Pennsylvania-based company ...